Table 2 Risk factors for HBsAg seropositivity
Univariate analysis | Multivariate analysis | |||||||
|---|---|---|---|---|---|---|---|---|
Factor | No. of patients with data | HBsAg positivity | OR | 95% CI | P | aOR | 95% CI | P |
Age (years) | ||||||||
≤ 30 | 40 | 8 (20.0) | 3.48 | 1.42–8.48 | 0.006 | 5.00 | 1.96–12.76 | 0.001 |
31–49 | 438 | 38 (8.7) | 1.32 | 0.76–2.30 | 0.33 | 1.78 | 1.00–2.21 | 0.05 |
≥ 50 | 313 | 21 (6.7) | REF | - | - | REF | - | - |
Gender | ||||||||
Male | 319 | 36 (11.3) | 1.81 | 1.09–2.99 | 0.02 | 2.15 | 1.25–3.69 | 0.005 |
Female | 472 | 31 (6.6) | REF | - | - | REF | - | - |
HIV-type | ||||||||
HIV-2 | 447 | 42 (9.4) | 1.59 | 0.77–3.27 | 0.21 | 1.66 | 0.85–3.26 | 0.14 |
HIV-1/2 | 152 | 11 (7.2) | 1.10 | 0.44–2.72 | 0.84 | 1.11 | 0.48–2.56 | 0.81 |
HIV-1 | 192 | 14 (7.3) | REF | - | - | REF | - | - |
Country | ||||||||
Burkina Faso | 232 | 21 (9.1) | 1.11 | 0.64–1.91 | 0.71 | 1.30 | 0.72–2.36 | 0.38 |
Mali | 24 | 24 (8.3) | 1.01 | 0.23–4.46 | 0.98 | 1.01 | 0.20–4.34 | 0.93 |
Côte d’Ivoire | 535 | 44 (8.2) | REF | - | - | REF | - | - |
CD4 count (cells/mm3) | ||||||||
≤ 200 | 115 | 13 (11.3) | 1.47 | 0.77–2.79 | 0.24 | 1.43 | 0.72–2.84 | 0.31 |
> 200 | 676 | 54 (8.0) | REF | - | - | REF | - | - |
Antiretroviral treatment | ||||||||
Yes | 555 | 51 (9.2) | 1.39 | 0.78–2.49 | 0.24 | 1.56 | 0.83–2.95 | 0.17 |
No | 236 | 16 (6.8) | REF | - | - | REF | - | - |